SEC Form 3 · accession 0001714522-17-000001
Oncolix, Inc. · ONCX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Aug 3, 2017
Accepted (ET)
Aug 11, 2017 · 1:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001584137
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 48,000,000 | D | ||
| Series A Preferred Stock | holding | — | — | — | 19,938,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant to acquire Series A Preferred | $0.0825 | holding | — | — | — | Aug 3, 2017 | Jan 16, 2020 | Series A Preferred Stock | 19,938,500 | — | D |